1. Home
  2. ZVRA vs MSBI Comparison

ZVRA vs MSBI Comparison

Compare ZVRA & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • MSBI
  • Stock Information
  • Founded
  • ZVRA 2006
  • MSBI 1881
  • Country
  • ZVRA United States
  • MSBI United States
  • Employees
  • ZVRA N/A
  • MSBI N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • MSBI Major Banks
  • Sector
  • ZVRA Health Care
  • MSBI Finance
  • Exchange
  • ZVRA Nasdaq
  • MSBI Nasdaq
  • Market Cap
  • ZVRA 473.6M
  • MSBI 505.5M
  • IPO Year
  • ZVRA 2015
  • MSBI 2016
  • Fundamental
  • Price
  • ZVRA $9.09
  • MSBI $26.77
  • Analyst Decision
  • ZVRA Strong Buy
  • MSBI Hold
  • Analyst Count
  • ZVRA 7
  • MSBI 4
  • Target Price
  • ZVRA $21.20
  • MSBI $26.75
  • AVG Volume (30 Days)
  • ZVRA 677.5K
  • MSBI 91.9K
  • Earning Date
  • ZVRA 11-12-2024
  • MSBI 10-24-2024
  • Dividend Yield
  • ZVRA N/A
  • MSBI 4.64%
  • EPS Growth
  • ZVRA N/A
  • MSBI N/A
  • EPS
  • ZVRA N/A
  • MSBI 2.30
  • Revenue
  • ZVRA $24,489,000.00
  • MSBI $259,944,000.00
  • Revenue This Year
  • ZVRA N/A
  • MSBI N/A
  • Revenue Next Year
  • ZVRA $318.48
  • MSBI $0.04
  • P/E Ratio
  • ZVRA N/A
  • MSBI $11.40
  • Revenue Growth
  • ZVRA 47.85
  • MSBI N/A
  • 52 Week Low
  • ZVRA $4.20
  • MSBI $20.54
  • 52 Week High
  • ZVRA $9.30
  • MSBI $28.47
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 59.84
  • MSBI 62.27
  • Support Level
  • ZVRA $8.32
  • MSBI $25.75
  • Resistance Level
  • ZVRA $9.27
  • MSBI $27.92
  • Average True Range (ATR)
  • ZVRA 0.53
  • MSBI 0.83
  • MACD
  • ZVRA 0.00
  • MSBI -0.10
  • Stochastic Oscillator
  • ZVRA 81.82
  • MSBI 74.00

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

Share on Social Networks: